Victory Capital Management
ALIM

Victory Capital Management’s Alimera Sciences ALIM Stock Holding History

Victory Capital Management’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,274
Closed -$6K – 3391
2020
Q1 		$6K Buy
+1,274
New +$7.75K ﹤0.01% 3461
2019
Q4 		– Sell
-752
Closed -$6K – 3379
2019
Q3 		$6K Buy
+752
New +$6.83K ﹤0.01% 3423

Other funds holding ALIM

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management's ALIM Position: Q2 2020 in Review

Victory Capital Management sold out of Alimera Sciences (ALIM) in Q2 2020, closing a stake of 1,274 shares — an estimated $6K sold.

Victory Capital Management first reported a position in ALIM in Q3 2019 and held it in 2 quarters. The position peaked at $6K in Q1 2020. 19 funds tracked by Wall St. Rank hold ALIM as of Q2 2020.

  • Victory Capital Management reported no remaining Alimera Sciences position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 1,274 Alimera Sciences shares in Q2 2020, an estimated $6K.
  • Victory Capital Management first reported a position in Alimera Sciences in Q3 2019 and held it in 2 quarters.
  • Victory Capital Management's Alimera Sciences position peaked at $6K in Q1 2020.
  • 19 funds tracked by Wall St. Rank held Alimera Sciences as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.